Open Access 01-12-2014 | Meeting abstract
EHMTI-0178. CGRP monoclonal antibody LY2951742 for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study
Published in: The Journal of Headache and Pain | Special Issue 1/2014
Login to get access